Los Angeles Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,077
| Closed | -$93.2K | – | 1173 |
|
|
2024
Q2 | $93.2K | Sell |
22,077
-65,854
| -75% | -$278K | ﹤0.01% | 1153 |
|
|
2024
Q1 | $448K | Buy |
87,931
+29,844
| +51% | +$152K | ﹤0.01% | 909 |
|
|
2023
Q4 | $541K | Buy |
58,087
+37,867
| +187% | +$353K | ﹤0.01% | 847 |
|
|
2023
Q3 | $132K | Buy |
+20,220
| New | +$132K | ﹤0.01% | 1083 |
|
|
2022
Q4 | – | Sell |
-14,599
| Closed | -$151K | – | 1191 |
|
|
2022
Q3 | $151K | Buy |
+14,599
| New | +$151K | ﹤0.01% | 1191 |
|